Skip to search formSkip to main contentSkip to account menu

pradofloxacin

Known as: 8-cyano-1-cyclopropyl-6-fluoro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydoquinoline-3-carboxylic acid 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (1)

Fluoroquinolones
Pradofloxacin:Susc:Pt:Isolate:OrdQn:MICpradofloxacin 25 MG/ML Oral Suspension [Veraflox]

Narrower (1)

Veraflox

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Pharmacokinetics and pharmacodynamics of oral pradofloxacin administration in dogs.
2019
2019
Mystery or Mycobacterium? Lessons learned from a challenging incision site infection
An eight-month-old female domestic short hair cat underwent routine ovariohysterectomy and was adopted from a shelter nine days… 
2017
2017
Influence of long-term oral application of quinolones on the ECG curve in dogs.
The aim of the study was to analyse the influence of enrofloxacin and pradofloxacin administered orally for 14 days on the ECG in… 
2014
2014
Emergence and maintenance of multidrug-resistant Escherichia coli of canine origin harbouring a blaCMY-2-IncI1/ST65 plasmid and topoisomerase mutations.
OBJECTIVES To characterize the mechanisms implicated in fluoroquinolone (FQ) and expanded-spectrum cephalosporin (ESC) resistance… 
2014
2014
Mutant prevention concentrations of pradofloxacin for susceptible and mutant strains of Escherichia coli with reduced fluoroquinolone susceptibility.
2012
2012
In vitro potency and efficacy favor later generation fluoroquinolones for treatment of canine and feline Escherichia coli uropathogens in the United States
Information regarding in vitro activity of newer fluoroquinolones (FQs) is limited despite increasing resistance in canine or… 
2011
2011
Susceptibility of rapidly growing mycobacteria and Nocardia isolates from cats and dogs to pradoflox
2008
2008
periodontal 1 disease in dogs – susceptibility test data from a European multi-centre study 2 3
4 Department of Biomedical Sciences, University of Bradford, Bradford, UK 8 9 Corresponding Author: Professor Silley 10 Telephone… 
2005
2005
Entwicklung zellulärer und molekularbiologischer Testsysteme zur Bestimmung der Aktivität von Fluorchinolonen auf Typ II-Topoisomerasen am Beispiel von Pradofloxacin - einem neuen C8…
Pradofloxacin – ein neues C8-Cyanofluorchinolon – wurde fur die Behandlung bakterieller Infektionen im veterinarmedizinischen… 
2003
2003
Pharmaceutical preparations for oral administration containing ion exchange resins loaded with pradofloxacin also intrinsically viscous gelling agents as thickeners.
Liquid pharmaceutical preparation comprising pradofloxacin bound to an ion exchanger, wherein the loaded ion exchanger is… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)